State AG sues maker of drug Plavix
HONOLULU — Hawaii’s attorney general is suing the makers of a widely prescribed blood thinner he says a significant portion of the state’s population has difficulty metabolizing.
Attorney General David Louie filed a lawsuit Wednesday against the manufacturers and distributors of Plavix, marketed to work similarly to aspirin to prevent a stroke or heart attack.
Louie alleges the manufacturers failed to disclose Plavix has “diminished or no effect” on people of East Asian or Pacific Islander descent because they metabolize it poorly. He said the drug puts them at risk for gastrointestinal bleeding and other complications. He wasn’t aware of any deaths as a result.
The suit names Bristol-Myers Squibb and Sanofi-Aventis as defendants. In a joint statement, the companies said they won’t comment on pending litigation.
“For a very significant portion of our population, the drug had no effect,” Louie said.
He said more than 1 million Plavix prescriptions have been issued in Hawaii since 1998, when the drug first started being marketed. It’s estimated the manufacturers made tens of millions in profits from those sales, including at the state’s expense through Medicaid, Louie said.
Hawaii is the fifth state to file a Plavix lawsuit, after Louisiana, Mississippi, West Virginia and California, said Richard Fried of the Honolulu law firm the attorney general’s office hired to handle the lawsuit.
To work effectively, Plavix must be broken down by a particular liver enzyme. But the Food and Drug Administration says 2 to 14 percent of people in the U.S. have low levels of the enzyme, preventing them from successfully processing Plavix. The likelihood of being a non-responder varies by race, according to the FDA.
Plavix’s “diminished effectiveness is especially prevalent among Hawaii consumers,” the suit said.
According to 2010 Census data, Asians constitute nearly 39 percent of Hawaii’s population; Pacific Islanders make up 10 percent; and nearly 24 percent of people in Hawaii are of mixed race.
Rules for posting comments
Comments posted below are from readers. In no way do they represent the view of Oahu Publishing Inc. or this newspaper. This is a public forum.
Comments may be monitored for inappropriate content but the newspaper is under no obligation to do so. Comment posters are solely responsible under the Communications Decency Act for comments posted on this Web site. Oahu Publishing Inc. is not liable for messages from third parties.
IP and email addresses of persons who post are not treated as confidential records and will be disclosed in response to valid legal process.
Do not post:
- Potentially libelous statements or damaging innuendo.
- Obscene, explicit, or racist language.
- Copyrighted materials of any sort without the express permission of the copyright holder.
- Personal attacks, insults or threats.
- The use of another person's real name to disguise your identity.
- Comments unrelated to the story.
If you believe that a commenter has not followed these guidelines, please click the FLAG icon below the comment.